Life Sciences

About Carlcorp Life Sciences

Carlcorp Life Sciences invests in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe, with a focus on companies that both drive medical innovation across the value chain and enable that innovation to improve the lives of patients with unmet medical needs. The differentiated skillset of Carlcorp Life Sciences team enables it to deliver targeted capital and value-added strategic support to companies around critical phases of growth and inflections in value.

Since 2000, Carlcorp has employed a strategic and analytical approach to identify attractive investment opportunities and partner with management teams to transform and improve their businesses. During this time, Carlcorp has developed global reach, deep expertise, and a proven track record in the life sciences industries across private equity, public equity, credit, venture capital, and real estate.

By the Numbers


Assets Unber Management




Trials Funded


Board Positions

Carlcorp Healthcare

We have built one of the largest and deepest healthcare investing teams in the world.


Carlcorp Life Sciences targets four types of investment opportunities:


Inflection Capital

Engaging with companies at the critical development stages of innovation.

Growth Capital

Partnering with companies to accelerate and expand platforms.


Fallen Angels

Engaging with companies at a crossroads to create value.

Larger Private Equity Collaborations and New Company Formation

Leveraging the Carlcorp platform to invest in, build, and support companies.


Guiding Principles

Carlcorp Life Sciences seeks to create differentiated value by identifying investments in companies that have these key features:

Research organizations that drive innovation across the healthcare value chain.

Pipelines with breakthrough products addressing unmet needs of patients.

Management teams that deploy capital efficiently to scale their business.